Cushing’s Syndrome - 08/08/11
Doi : 10.1016/j.ecl.2007.10.010
Rosario Pivonello, MD, PhD ⁎ 
, Maria Cristina De Martino, MD, Monica De Leo, MD, Gaetano Lombardi, MD, Annamaria Colao, MD, PhD
, Maria Cristina De Martino, MD, Monica De Leo, MD, Gaetano Lombardi, MD, Annamaria Colao, MD, PhD Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Via Sergio Pansini 5, 80131 Naples, Italy
Corresponding author.Abstract |
Cushing’s syndrome is a rare endocrine disease characterized by cortisol hypersecretion, induced mainly by a pituitary tumor (Cushing’s disease) or, rarely, by an adrenal or an ectopic neuroendocine tumor. Cushing’s syndrome is associated with severe morbidities and an increased mortality. The major systemic complications and the main cause of death are represented by cardiovascular disease. The prognosis of the disease is mainly affected by the difficulties in the diagnosis and treatment of the disease, which remain a considerable challenge.
Le texte complet de cet article est disponible en PDF.Plan
© 2008
Elsevier Inc. Tous droits réservés.
Vol 37 - N° 1
P. 135-149 - mars 2008 Retour au numéro
Article précédent
- Thyrotropinomas
- Paolo Beck-Peccoz, Luca Persani
- Nonfunctioning Pituitary Tumors and Pituitary Incidentalomas
- Mark E. Molitch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?